Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenue $ 43,544,000 $ 36,230,000 $ 124,776,000 $ 104,432,000
Cost of revenue 13,609,000 13,023,000 40,266,000 40,525,000
Gross profit 29,935,000 23,207,000 84,510,000 63,907,000
Operating expenses:        
Sales and marketing 17,801,000 16,292,000 52,474,000 49,259,000
Research and development 8,628,000 7,897,000 24,907,000 22,529,000
General and administrative 11,528,000 10,876,000 33,502,000 32,077,000
Total operating expenses 37,957,000 35,065,000 110,883,000 103,865,000
Loss from operations (8,022,000) (11,858,000) (26,373,000) (39,958,000)
Other income (expense):        
Interest income 594,000 468,000 1,557,000 606,000
Interest expense (512,000) (380,000) (1,485,000) (1,005,000)
Other income (expense), net 874,000 (17,000) 2,457,000 (32,000)
Loss before income taxes (7,066,000) (11,787,000) (23,844,000) (40,389,000)
Provision for income taxes (79,000) (30,900) (148,300) (82,000)
Net loss $ (7,145,000) $ (11,818,000) $ (23,992,000) $ (40,471,000)
Net loss per share, basic (in dollars per share) $ (0.10) $ (0.18) $ (0.36) $ (0.62)
Net loss per share, diluted (in dollars per share) $ (0.10) $ (0.18) $ (0.36) $ (0.62)
Weighted-average common shares outstanding - basic (in shares) 68,213,250 65,143,929 67,014,127 64,898,948
Weighted-average common shares outstanding - diluted (in shares) 68,213,250 65,143,929 67,014,127 64,898,948